JP2023505434A5 - - Google Patents
Info
- Publication number
- JP2023505434A5 JP2023505434A5 JP2022532614A JP2022532614A JP2023505434A5 JP 2023505434 A5 JP2023505434 A5 JP 2023505434A5 JP 2022532614 A JP2022532614 A JP 2022532614A JP 2022532614 A JP2022532614 A JP 2022532614A JP 2023505434 A5 JP2023505434 A5 JP 2023505434A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- group
- alkyl
- salt
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944963P | 2019-12-06 | 2019-12-06 | |
| US62/944,963 | 2019-12-06 | ||
| PCT/US2020/063617 WO2021113820A1 (en) | 2019-12-06 | 2020-12-07 | Conjugates and methods for treating liver fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505434A JP2023505434A (ja) | 2023-02-09 |
| JP2023505434A5 true JP2023505434A5 (https=) | 2023-12-13 |
Family
ID=76222671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532614A Pending JP2023505434A (ja) | 2019-12-06 | 2020-12-07 | 肝線維症を治療するためのコンジュゲート及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220387600A1 (https=) |
| EP (1) | EP4069276A4 (https=) |
| JP (1) | JP2023505434A (https=) |
| KR (1) | KR20220112788A (https=) |
| CN (1) | CN115884984A (https=) |
| AU (1) | AU2020398708A1 (https=) |
| BR (1) | BR112022010613A2 (https=) |
| CA (1) | CA3163911A1 (https=) |
| IL (1) | IL293560A (https=) |
| MX (1) | MX2022006846A (https=) |
| NZ (1) | NZ788988A (https=) |
| WO (1) | WO2021113820A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3020585A1 (en) * | 2016-04-11 | 2017-10-19 | Arbutus Biopharma Corporation | Targeted nucleic acid conjugate compositions |
| CN118234862A (zh) * | 2021-09-08 | 2024-06-21 | 阿利戈斯治疗公司 | 经修饰的短干扰核酸分子(siNA)及其用途 |
| WO2024175062A1 (zh) * | 2023-02-23 | 2024-08-29 | 大睿生物医药科技(上海)有限公司 | 调控KHK基因活性的dsRNA分子 |
| US20240352464A1 (en) * | 2023-03-07 | 2024-10-24 | Aligos Therapeutics, Inc. | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof |
| CN119219716A (zh) * | 2023-06-30 | 2024-12-31 | 上海维申医药有限公司 | 新型GalNAc的靶向递送片段及其制备和应用 |
| WO2025255972A1 (zh) * | 2024-06-13 | 2025-12-18 | 广州必贝特医药股份有限公司 | 用于靶向递送寡核苷酸药物的化合物、缀合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3020585A1 (en) * | 2016-04-11 | 2017-10-19 | Arbutus Biopharma Corporation | Targeted nucleic acid conjugate compositions |
| MX2019012280A (es) * | 2017-04-11 | 2020-01-23 | Arbutus Biopharma Corp | Composiciones dirigidas. |
| WO2019051257A2 (en) * | 2017-09-11 | 2019-03-14 | Arbutus Biopharma Corporation | METHODS OF TREATING HEPATITIS B TYPE INFECTIONS |
| AU2019239971B2 (en) * | 2018-03-21 | 2025-09-11 | Regeneron Pharmaceuticals, Inc. | 17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof |
| EP3873530A4 (en) * | 2018-11-02 | 2022-11-09 | Genevant Sciences GmbH | THERAPEUTIC PROCESSES |
-
2020
- 2020-12-07 AU AU2020398708A patent/AU2020398708A1/en active Pending
- 2020-12-07 JP JP2022532614A patent/JP2023505434A/ja active Pending
- 2020-12-07 US US17/782,901 patent/US20220387600A1/en active Pending
- 2020-12-07 NZ NZ788988A patent/NZ788988A/en unknown
- 2020-12-07 IL IL293560A patent/IL293560A/en unknown
- 2020-12-07 EP EP20896461.9A patent/EP4069276A4/en active Pending
- 2020-12-07 MX MX2022006846A patent/MX2022006846A/es unknown
- 2020-12-07 KR KR1020227020501A patent/KR20220112788A/ko not_active Ceased
- 2020-12-07 CN CN202080091946.7A patent/CN115884984A/zh active Pending
- 2020-12-07 CA CA3163911A patent/CA3163911A1/en active Pending
- 2020-12-07 BR BR112022010613A patent/BR112022010613A2/pt not_active IP Right Cessation
- 2020-12-07 WO PCT/US2020/063617 patent/WO2021113820A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023505434A5 (https=) | ||
| US8653058B2 (en) | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits | |
| KR101919269B1 (ko) | 데옥시콜린산 및 그의 염들의 제형물들 | |
| RU2001118826A (ru) | N-замещенные 2-цианопирролидины | |
| JP2022522486A5 (https=) | ||
| IL234769A (en) | Parenteral formulations for administration of macrolide antibiotics | |
| US20100222376A1 (en) | Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders | |
| EP2561876B1 (en) | Formulations of Deoxycholic Acid and Salts Thereof | |
| US12310955B2 (en) | Cyclic amide compounds for rabies treatment and method thereof | |
| KR20110043774A (ko) | 말초 신경병증의 치료를 위한 화합물 | |
| WO2008094912B1 (en) | Substituted gamma lactams as therapeutic agents | |
| JP2022553056A5 (https=) | ||
| AU2009284224B2 (en) | Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies | |
| EP1868599B1 (en) | Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors | |
| RU2005126459A (ru) | Производные диазепана, используемые в качестве ингибиторов lfa | |
| WO2007077893A1 (ja) | 肝臓疾患治療剤及び肝機能改善剤 | |
| HK1126143A (en) | Therapeutic agent for liver disease and hepatic function-ameliorating agent | |
| HK1182629A (en) | Formulations of deoxycholic acid and salts thereof | |
| HK1182629B (en) | Formulations of deoxycholic acid and salts thereof |